Chd4 and Brg1: Chromatin Remodellers Battle For Control of Stem Cell Fate

Brian Hendrich received his PhD from Stanford University in 1995 working on X chromosome inactivation with Huntington Willard. In 1995 he joined the lab of Adrian Bird at the University of Edinburgh and participated in the discovery and characterisation of a family of methyl-CpG binding proteins in mammals. In 2001 he started his own laboratory at the University of Edinburgh studying the function of the Nucleosome Remodelling and Deacetylation complex in pluripotent cells in mice . In 2008 he moved to the Wellcome Trust Centre for Stem Cell Research in Cambridge where his lab focusses on chromatin remodelling and transcriptional control in pluripotency and early mouse development. He is currently a Principal Research Associate and Director of the PhD Programme in Stem Cell Biology and Medicine for the Wellcome – MRC Cambridge Stem Cell Institute.